Lake Street Private Wealth LLC Has $3.91 Million Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Lake Street Private Wealth LLC lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 6.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 9,777 shares of the biotechnology company’s stock after selling 692 shares during the period. Lake Street Private Wealth LLC’s holdings in Axon Enterprise were worth $3,907,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Avantax Advisory Services Inc. grew its holdings in Axon Enterprise by 0.8% during the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after acquiring an additional 40 shares during the period. GSA Capital Partners LLP bought a new position in shares of Axon Enterprise during the first quarter worth $931,000. Zurich Insurance Group Ltd FI boosted its position in shares of Axon Enterprise by 1.9% during the second quarter. Zurich Insurance Group Ltd FI now owns 205,015 shares of the biotechnology company’s stock worth $60,324,000 after purchasing an additional 3,832 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of Axon Enterprise by 14.8% during the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 170,376 shares of the biotechnology company’s stock worth $53,307,000 after purchasing an additional 22,013 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its position in shares of Axon Enterprise by 21.7% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 9,153 shares of the biotechnology company’s stock worth $2,693,000 after purchasing an additional 1,634 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of the firm’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the transaction, the president now directly owns 228,166 shares of the company’s stock, valued at approximately $82,103,253.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Patrick W. Smith sold 80,300 shares of the firm’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at $1,121,052,771.48. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, President Joshua Isner sold 25,811 shares of the stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the transaction, the president now directly owns 228,166 shares of the company’s stock, valued at $82,103,253.44. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 371,172 shares of company stock valued at $137,000,162. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Down 1.0 %

NASDAQ AXON traded down $4.28 on Wednesday, hitting $445.33. 73,021 shares of the company were exchanged, compared to its average volume of 519,202. The company has a market cap of $33.65 billion, a PE ratio of 118.63, a PEG ratio of 11.74 and a beta of 0.94. Axon Enterprise, Inc. has a 12 month low of $199.29 and a 12 month high of $455.17. The stock has a fifty day moving average of $391.84 and a 200-day moving average of $333.90. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million for the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. Axon Enterprise’s revenue was up 34.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.80 earnings per share. As a group, analysts forecast that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on AXON shares. Needham & Company LLC lifted their price target on shares of Axon Enterprise from $400.00 to $525.00 and gave the company a “buy” rating in a research note on Tuesday. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a report on Tuesday, September 10th. Barclays upped their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Northland Securities upped their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Finally, Craig Hallum increased their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $375.00.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.